Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297)

Jose Alberto Choreño-Parra; Luis Armando Jiménez-Álvarez; Gustavo Ramírez-Martínez; Montserrat Sandoval-Vega; Citlaltepetl Salinas-Lara; Carlos Sánchez-Garibay; Cesar Luna-Rivero; Erika Mariana Hernández-Montiel; Luis Alejandro Fernández-López; María Fernanda Cabrera-Cornejo; Eduardo Misael Choreño-Parra; Alfredo Cruz-Lagunas; Andrea Domínguez; Eduardo Márquez-García; Carlos Cabello-Gutiérrez; Francina Valezka Bolaños-Morales; Lourdes Mena-Hernández; Diego Delgado-Zaldivar; Daniel Rebolledo-García; Parménides Guadarrama-Ortiz; Nora E. Regino-Zamarripa; Criselda Mendoza-Milla; Ethel A. García-Latorre; Tatiana Sofía Rodríguez-Reyna; Diana Cervántes-Rosete; Carmen M. Hernández-Cárdenas; Shabaana A. Khader; Albert Zlotnik; Joaquín Zúñiga

doi:10.3389/fimmu.2021.700716

Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297)

Jose Alberto Choreño-Parra, Luis Armando Jiménez-Álvarez, Gustavo Ramírez-Martínez, Montserrat Sandoval-Vega, Citlaltepetl Salinas-Lara, Carlos Sánchez-Garibay, Cesar Luna-Rivero, Erika Mariana Hernández-Montiel, Luis Alejandro Fernández-López, María Fernanda Cabrera-Cornejo, Eduardo Misael Choreño-Parra, Alfredo Cruz-Lagunas, Andrea Domínguez, Eduardo Márquez-García, Carlos Cabello-Gutiérrez, Francina Valezka Bolaños-Morales, Lourdes Mena-Hernández, Diego Delgado-Zaldivar, Daniel Rebolledo-García, Parménides Guadarrama-OrtizNora E. Regino-Zamarripa, Criselda Mendoza-Milla, Ethel A. García-Latorre, Tatiana Sofía Rodríguez-Reyna, Diana Cervántes-Rosete, Carmen M. Hernández-Cárdenas, Shabaana A. Khader, Albert Zlotnik, Joaquín Zúñiga

Research output: Contribution to journal › Comment/debate

Abstract

An author name was incorrectly spelled as Tatiana Sofia Rodiguez-Reyna. The correct spelling is Tatiana Sofı́a Rodrı́guez-Reyna. In the published article, there was also an error in the affiliation of Criselda Mendoza-Milla. Instead of “Laboratorio de Inmunobiologı́a y Genética, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosı́o Villegas”, Mexico City, Mexico”, it should be “Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosı́o Villegas”, Mexico City, Mexico”. The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Original language	English
Article number	700716
Journal	Frontiers in immunology
Volume	12
DOIs	https://doi.org/10.3389/fimmu.2021.700716
State	Published - May 13 2021

Keywords

COVID-19
CXCL17
SARS-CoV-2
chemokines
influenza A(H1N1)
tuberculosis

Access to Document

10.3389/fimmu.2021.700716

Cite this

Choreño-Parra, J. A., Jiménez-Álvarez, L. A., Ramírez-Martínez, G., Sandoval-Vega, M., Salinas-Lara, C., Sánchez-Garibay, C., Luna-Rivero, C., Hernández-Montiel, E. M., Fernández-López, L. A., Cabrera-Cornejo, M. F., Choreño-Parra, E. M., Cruz-Lagunas, A., Domínguez, A., Márquez-García, E., Cabello-Gutiérrez, C., Bolaños-Morales, F. V., Mena-Hernández, L., Delgado-Zaldivar, D., Rebolledo-García, D., ... Zúñiga, J. (2021). Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297). Frontiers in immunology, 12, Article 700716. https://doi.org/10.3389/fimmu.2021.700716

@article{b8420e483e8a4468937991a4b8338130,

title = "Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297)",

abstract = "An author name was incorrectly spelled as Tatiana Sofia Rodiguez-Reyna. The correct spelling is Tatiana Sof{\'ı}a Rodr{\'ı}guez-Reyna. In the published article, there was also an error in the affiliation of Criselda Mendoza-Milla. Instead of “Laboratorio de Inmunobiolog{\'ı}a y Gen{\'e}tica, Instituto Nacional de Enfermedades Respiratorias “Ismael Cos{\'ı}o Villegas”, Mexico City, Mexico”, it should be “Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias “Ismael Cos{\'ı}o Villegas”, Mexico City, Mexico”. The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.",

keywords = "COVID-19, CXCL17, SARS-CoV-2, chemokines, influenza A(H1N1), tuberculosis",

author = "Chore{\~n}o-Parra, {Jose Alberto} and Jim{\'e}nez-{\'A}lvarez, {Luis Armando} and Gustavo Ram{\'i}rez-Mart{\'i}nez and Montserrat Sandoval-Vega and Citlaltepetl Salinas-Lara and Carlos S{\'a}nchez-Garibay and Cesar Luna-Rivero and Hern{\'a}ndez-Montiel, {Erika Mariana} and Fern{\'a}ndez-L{\'o}pez, {Luis Alejandro} and Cabrera-Cornejo, {Mar{\'i}a Fernanda} and Chore{\~n}o-Parra, {Eduardo Misael} and Alfredo Cruz-Lagunas and Andrea Dom{\'i}nguez and Eduardo M{\'a}rquez-Garc{\'i}a and Carlos Cabello-Guti{\'e}rrez and Bola{\~n}os-Morales, {Francina Valezka} and Lourdes Mena-Hern{\'a}ndez and Diego Delgado-Zaldivar and Daniel Rebolledo-Garc{\'i}a and Parm{\'e}nides Guadarrama-Ortiz and Regino-Zamarripa, {Nora E.} and Criselda Mendoza-Milla and Garc{\'i}a-Latorre, {Ethel A.} and Rodr{\'i}guez-Reyna, {Tatiana Sof{\'i}a} and Diana Cerv{\'a}ntes-Rosete and Hern{\'a}ndez-C{\'a}rdenas, {Carmen M.} and Khader, {Shabaana A.} and Albert Zlotnik and Joaqu{\'i}n Z{\'u}{\~n}iga",

note = "Publisher Copyright: Copyright {\textcopyright} 2021 Chore{\~n}o-Parra, Jim{\'e}nez-{\'A} lvarez, Ram{\'ı}rez-Mart{\'ı}nez, Sandoval-Vega, Salinas-Lara, S{\'a}nchez-Garibay, Luna-Rivero, Hern{\'a}ndez-Montiel, Fern{\'a}ndez-L{\'o}pez, Cabrera-Cornejo, Chore{\~n}o-Parra, Cruz-Lagunas, Dom{\'ı}nguez, M{\'a}rquez-Garc{\'ı}a, Cabello-Guti{\'e}rrez, Bola{\~n}os-Morales, Mena-Hern{\'a}ndez, Delgado-Zaldivar, Rebolledo-Garc{\'ı}a, Guadarrama-Ortiz, Regino-Zamarripa, Mendoza-Milla, Garc{\'ı}a-Latorre, Rodr{\'ı}guez-Reyna, Cerv{\'a}ntes-Rosete, Hern{\'a}ndez-C{\'a}rdenas, Khader, Zlotnik and Z{\'u}{\~n}iga.",

year = "2021",

month = may,

day = "13",

doi = "10.3389/fimmu.2021.700716",

language = "English",

volume = "12",

journal = "Frontiers in immunology",

issn = "1664-3224",

}

Choreño-Parra, JA, Jiménez-Álvarez, LA, Ramírez-Martínez, G, Sandoval-Vega, M, Salinas-Lara, C, Sánchez-Garibay, C, Luna-Rivero, C, Hernández-Montiel, EM, Fernández-López, LA, Cabrera-Cornejo, MF, Choreño-Parra, EM, Cruz-Lagunas, A, Domínguez, A, Márquez-García, E, Cabello-Gutiérrez, C, Bolaños-Morales, FV, Mena-Hernández, L, Delgado-Zaldivar, D, Rebolledo-García, D, Guadarrama-Ortiz, P, Regino-Zamarripa, NE, Mendoza-Milla, C, García-Latorre, EA, Rodríguez-Reyna, TS, Cervántes-Rosete, D, Hernández-Cárdenas, CM, Khader, SA, Zlotnik, A & Zúñiga, J 2021, 'Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297)', Frontiers in immunology, vol. 12, 700716. https://doi.org/10.3389/fimmu.2021.700716

Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297). / Choreño-Parra, Jose Alberto; Jiménez-Álvarez, Luis Armando; Ramírez-Martínez, Gustavo et al.
In: Frontiers in immunology, Vol. 12, 700716, 13.05.2021.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum

T2 - CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297)

AU - Choreño-Parra, Jose Alberto

AU - Jiménez-Álvarez, Luis Armando

AU - Ramírez-Martínez, Gustavo

AU - Sandoval-Vega, Montserrat

AU - Salinas-Lara, Citlaltepetl

AU - Sánchez-Garibay, Carlos

AU - Luna-Rivero, Cesar

AU - Hernández-Montiel, Erika Mariana

AU - Fernández-López, Luis Alejandro

AU - Cabrera-Cornejo, María Fernanda

AU - Choreño-Parra, Eduardo Misael

AU - Cruz-Lagunas, Alfredo

AU - Domínguez, Andrea

AU - Márquez-García, Eduardo

AU - Cabello-Gutiérrez, Carlos

AU - Bolaños-Morales, Francina Valezka

AU - Mena-Hernández, Lourdes

AU - Delgado-Zaldivar, Diego

AU - Rebolledo-García, Daniel

AU - Guadarrama-Ortiz, Parménides

AU - Regino-Zamarripa, Nora E.

AU - Mendoza-Milla, Criselda

AU - García-Latorre, Ethel A.

AU - Rodríguez-Reyna, Tatiana Sofía

AU - Cervántes-Rosete, Diana

AU - Hernández-Cárdenas, Carmen M.

AU - Khader, Shabaana A.

AU - Zlotnik, Albert

AU - Zúñiga, Joaquín

N1 - Publisher Copyright: Copyright © 2021 Choreño-Parra, Jiménez-Á lvarez, Ramı́rez-Martı́nez, Sandoval-Vega, Salinas-Lara, Sánchez-Garibay, Luna-Rivero, Hernández-Montiel, Fernández-López, Cabrera-Cornejo, Choreño-Parra, Cruz-Lagunas, Domı́nguez, Márquez-Garcı́a, Cabello-Gutiérrez, Bolaños-Morales, Mena-Hernández, Delgado-Zaldivar, Rebolledo-Garcı́a, Guadarrama-Ortiz, Regino-Zamarripa, Mendoza-Milla, Garcı́a-Latorre, Rodrı́guez-Reyna, Cervántes-Rosete, Hernández-Cárdenas, Khader, Zlotnik and Zúñiga.

PY - 2021/5/13

Y1 - 2021/5/13

N2 - An author name was incorrectly spelled as Tatiana Sofia Rodiguez-Reyna. The correct spelling is Tatiana Sofı́a Rodrı́guez-Reyna. In the published article, there was also an error in the affiliation of Criselda Mendoza-Milla. Instead of “Laboratorio de Inmunobiologı́a y Genética, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosı́o Villegas”, Mexico City, Mexico”, it should be “Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosı́o Villegas”, Mexico City, Mexico”. The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

AB - An author name was incorrectly spelled as Tatiana Sofia Rodiguez-Reyna. The correct spelling is Tatiana Sofı́a Rodrı́guez-Reyna. In the published article, there was also an error in the affiliation of Criselda Mendoza-Milla. Instead of “Laboratorio de Inmunobiologı́a y Genética, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosı́o Villegas”, Mexico City, Mexico”, it should be “Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosı́o Villegas”, Mexico City, Mexico”. The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

KW - COVID-19

KW - CXCL17

KW - SARS-CoV-2

KW - chemokines

KW - influenza A(H1N1)

KW - tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85107073039&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2021.700716

DO - 10.3389/fimmu.2021.700716

M3 - Comment/debate

C2 - 34054884

AN - SCOPUS:85107073039

SN - 1664-3224

VL - 12

JO - Frontiers in immunology

JF - Frontiers in immunology

M1 - 700716

ER -

Choreño-Parra JA, Jiménez-Álvarez LA, Ramírez-Martínez G, Sandoval-Vega M, Salinas-Lara C, Sánchez-Garibay C et al. Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297). Frontiers in immunology. 2021 May 13;12:700716. doi: 10.3389/fimmu.2021.700716

Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297)

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this